Clinical trial
Effect of PI3K Inhibition in HPV-Associated HNSCC
NCT00897988 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of PI3K Inhibition in HPV-Associated HNSCC
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- Not reported
- Enrollment
- 40 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer